Cowealth Medical China Co.,Ltd. (SHA:603122)
China · Delayed Price · Currency is CNY 9.90
-0.41 (-3.98%)
Jul 20, 2026, 4:00 PM EDT
Cowealth Medical China Market Cap
Cowealth Medical China has a market cap or net worth of 3.94 billion as of July 20, 2026. Its market cap has increased by 38.85% in one year.
Market Cap
3.94B
Enterprise Value
3.92B
Revenue
656.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.90
ChartMarket Cap Chart
Since February 16, 2022, Cowealth Medical China's market cap has increased from 2.40B to 3.94B, an increase of 64.18%. That is a compound annual growth rate of 11.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 3.94B | -59.43% |
| Dec 31, 2025 | 9.71B | 248.07% |
| Dec 31, 2024 | 2.79B | -12.92% |
| Dec 29, 2023 | 3.20B | -28.13% |
| Dec 30, 2022 | 4.46B | 85.74% |
| Feb 16, 2022 | 2.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.79B |
| Beijing Strong Biotechnologies,Inc. | 6.67B |
| Shanghai Runda Medical Technology | 5.85B |
| Maccura Biotechnology Co.Ltd | 5.48B |
| SMO ClinPlus CO.,LTD. | 4.30B |
| Shanghai Labway Clinical Laboratory | 3.53B |
| Medicalsystem Biotechnology | 3.34B |
| Guangdong Hybribio Biotech | 3.29B |